HOME >> MEDICINE >> NEWS
Clinical Trials Units selected for newly restructured HIV/AIDS research networks

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced 60 U.S. and international institutions selected as HIV/AIDS Clinical Trials Units (CTUs) in a newly restructured system of six HIV/AIDS clinical research networks. NIAID expects to fund additional CTUs within the next several months, bringing the total to 73.

These Clinical Trials Units will carry out the next generation of HIV/AIDS vaccine, prevention and treatment research, says NIAID Director Anthony S. Fauci, M.D. They will work with our clinical research networks in a flexible, collaborative and coordinated way to tackle the critical research questions that can help accelerate progress against the HIV/AIDS pandemic. NIAID supports the worlds largest HIV/AIDS clinical research effort.

The CTU awards represent the second step of a two-part restructuring process of NIAIDs HIV/AIDS clinical trials networks. NIAID announced the clinical investigators and institutions responsible for leading the new networks in June 2006 (see http://www3.niaid.nih.gov/news/newsreleases/2006/leadership.htm).

Each CTU is a member of one or more of the six NIAID HIV/AIDS networks: the AIDS Clinical Trials Group, the HIV Prevention Trials Network, the HIV Vaccine Trials Network, the International Maternal Pediatric Adolescent AIDS Clinical Trials Network, the International Network for Strategic Initiatives in Global HIV Trials, and the Microbicide Trials Network.

The HIV/AIDS networks and their CTUs will pursue an integrated research approach to conducting clinical trials designed to address the highest priorities in HIV/AIDS research, including

  • Developing a safe and effective HIV vaccine

  • Conducting research for new drug development designed to translate lab findings into clinical applications


'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
12-Mar-2007


Page: 1 2 3

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Clinical guidelines for blood conservation during cardiac procedures developed
7. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
8. Clinical trial coordinators need more financial conflict-of-interest training
9. Clinical studies evaluate potential treatments for mouth ulcers
10. NIH names Clinical Trial Units for the Microbicide Trials Network
11. Study in recent issue of Clinical Pediatrics helps pediatricians to understand discipline practices

Post Your Comments:
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... recognized by the independent auditor of customer service for the 40-center nursing home ... than 1,100 skilled nursing centers in the United States in one or more ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... filed against C.R. Bard, Inc. and Ethicon, Inc. continue to move forward ... next Case Management Conference is to be convened on Thursday, July 23rd at ...
(Date:6/29/2015)... ... ... USA Today reported on June 18th the overdose death rate has ... rest of the nation’s growing overdose death rates in 26 other states the U.S. ... stop the increasing overdose trend from continuing: , , Encourage and ...
(Date:6/29/2015)... ... June 29, 2015 , ... The world’s fastest and ... Aviation Museum to the Science Museum of Virginia. This iconic, supersonic stealth plane will ... , “Suspending a supersonic jet from the ceiling of a historic train station is ...
(Date:6/29/2015)... ... ... The Food Safety and Technology Research Centre under the ... (PolyU) has developed a new method for rapid authentication of edible oils and ... in food safety, and becomes particularly important with the emergence and widespread use ...
Breaking Medicine News(10 mins):Health News:National HealthCare Centers Receive 'Customer Experience Awards' 2Health News:National HealthCare Centers Receive 'Customer Experience Awards' 3Health News:National HealthCare Centers Receive 'Customer Experience Awards' 4Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4Health News:Overdose Death Rates Decreased in Florida as of 2015 2Health News:Overdose Death Rates Decreased in Florida as of 2015 3Health News:SR-71 Prepares for Flight to Science Museum of Virginia 2Health News:PolyU develops a new method for rapid authentication of edible oils and screening of gutter oils 2
(Date:6/29/2015)... June 29, 2015  Nevro Corp. (NYSE: NVRO ... innovative evidence-based solutions for the treatment of chronic pain, ... Chief Executive Officer of Intersect ENT (NASDAQ: XENT ... effective June 28, 2015. For the ... led Intersect ENT, a company dedicated to improving the ...
(Date:6/29/2015)... , June 29, 2015 ... positive preliminary results from its BVX-006 Phase II clinical ... vaccine. In this trial, M-001 was injected intramuscularly to ... by an administration of the 2014/15 season trivalent influenza ... be safe and well tolerated and induced humoral immune ...
(Date:6/29/2015)... Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a pharmaceutical ... of prescription ophthalmic pharmaceuticals, today announced that Rick ... will present at the 2015 Cantor Fitzgerald Inaugural Healthcare ... at Le Parker Meridien Hotel in New ... webcast live and will be available for access, along ...
Breaking Medicine Technology:Nevro Appoints Lisa Earnhardt to its Board of Directors 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3
Cached News: